Literature DB >> 2919690

Briquet's syndrome in association with depression and panic: a reconceptualization of Briquet's syndrome.

H Orenstein1.   

Abstract

In a sample of 188 consecutive female psychiatric patients, Briquet's syndrome was found to be associated more closely with the aggregation of both major depression and either panic disorder or agoraphobia than with major depression or panic disorder-agoraphobia alone. These results are consistent with the hypothesis of a shared diathesis underlying some cases of major depression, panic disorder, agoraphobia, and Briquet's syndrome. The author proposes that Briquet's syndrome may represent the most extreme expression of a tendency for a number of physical and psychological syndromes to aggregate.

Entities:  

Mesh:

Year:  1989        PMID: 2919690     DOI: 10.1176/ajp.146.3.334

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Somatization symptoms in pediatric abdominal pain patients: relation to chronicity of abdominal pain and parent somatization.

Authors:  L S Walker; J Garber; J W Greene
Journal:  J Abnorm Child Psychol       Date:  1991-08

Review 2.  Somatization in survivors of catastrophic trauma: a methodological review.

Authors:  Carol S North
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

3.  Mental Health and Physical Activity of Female Higher Education Students during the COVID-19 Pandemic: A Comparative Cross-Sectional Study from Lithuania.

Authors:  Marius Baranauskas; Ingrida Kupčiūnaitė; Rimantas Stukas
Journal:  Int J Environ Res Public Health       Date:  2022-08-07       Impact factor: 4.614

4.  Adolescent overweight and obesity and the risk of papillary thyroid cancer in adulthood: a large-scale case-control study.

Authors:  Kyoung-Nam Kim; Yunji Hwang; Kyu Hyung Kim; Kyu Eun Lee; Young Joo Park; Su-Jin Kim; Hyungju Kwon; Do Joon Park; BeLong Cho; Ho-Chun Choi; Daehee Kang; Sue K Park
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.